Stock Market News

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

May 20, 2025 - 02:06
 0
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
Read More

Tags:

Previous Article

Agilysys, Inc. (AGYS) Q4 2025 Earnings Call Transcript

Next Article

Alphabet's Waymo gets California nod for robotaxi expansion in San Francisco Bay...

Related Posts

Colombia stocks lower at close of trade; COLCAP down 0.67%

Colombia stocks lower at close of trade; COLCAP down 0.67%

May 15, 2025  0

Uber bets on affordability with shared fixed-route rides, expanded passes

Uber bets on affordability with shared fixed-route ride...

May 14, 2025  0

Sanmina to buy ZT Systems' manufacturing business from AMD in $3 billion deal

Sanmina to buy ZT Systems' manufacturing business from ...

May 19, 2025  0